: Extracellular Hsp90 (eHsp90) activates a number of client proteins outside of cancer cells required for migration and invasion.
EHsp90 may serve as a novel target for anti-metastatic drugs as its inhibition using impermeant Hsp90 inhibitors would not affect the numerous vital intracellular Hsp90 functions in normal cells.